Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

AXLA

Axcella Health (AXLA)

Axcella Health Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:AXLA
DateHeureSourceTitreSymboleSociété
22/12/202322h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXLAAxcella Health Inc
17/11/202314h47Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:AXLAAxcella Health Inc
17/11/202314h28Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AXLAAxcella Health Inc
06/11/202315h22Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:AXLAAxcella Health Inc
14/09/202322h30Business WireAxcella Announces Reverse Stock Split Effective September 19, 2023NASDAQ:AXLAAxcella Health Inc
29/08/202314h00Business WireAxcella Granted Patent for Long COVID Fatigue TreatmentNASDAQ:AXLAAxcella Health Inc
18/08/202322h20Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:AXLAAxcella Health Inc
03/08/202322h12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AXLAAxcella Health Inc
03/08/202313h30Business WireAxcella Reports Second Quarter Financial Results and Provides Business UpdateNASDAQ:AXLAAxcella Health Inc
29/06/202322h34Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AXLAAxcella Health Inc
04/05/202322h39Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AXLAAxcella Health Inc
04/05/202322h30Business WireAxcella Reports First Quarter Financial Results and Provides Business UpdateNASDAQ:AXLAAxcella Health Inc
17/04/202314h00Business WireAxcella Announces Two Oral Presentations on AXA1125 for Long COVID Fatigue at ECCMID 2023NASDAQ:AXLAAxcella Health Inc
30/03/202322h14Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AXLAAxcella Health Inc
30/03/202314h00Business WireAxcella Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business UpdateNASDAQ:AXLAAxcella Health Inc
03/03/202322h18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AXLAAxcella Health Inc
15/02/202322h10Business WireAxcella Announces FDA IND Clearance Supporting Regulatory Path to Registration of AXA1125 for Long COVID FatigueNASDAQ:AXLAAxcella Health Inc
14/02/202312h26Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AXLAAxcella Health Inc
09/02/202322h45Business WireAxcella Therapeutics to Participate in the SVB Securities’ 2023 Global Biopharma ConferenceNASDAQ:AXLAAxcella Health Inc
24/01/202315h20AllPennyStocks.comStrong Premarket Bid For This Micro CapNASDAQ:AXLAAxcella Health Inc
23/01/202323h03Dow Jones NewsAxcella Health Shares Surge 53% on U.K. Regulator Guidance on AXA1125 for Long Covid FatigueNASDAQ:AXLAAxcella Health Inc
23/01/202322h15Business WireAxcella Announces Regulatory Path to Registration of AXA1125 for Long COVID FatigueNASDAQ:AXLAAxcella Health Inc
15/12/202202h01Business WireAxcella Announces Program Reprioritization and Corporate RestructuringNASDAQ:AXLAAxcella Health Inc
04/11/202206h06TipRanksSVB Securities Keeps Their Buy Rating on Axcella Health (AXLA)NASDAQ:AXLAAxcella Health Inc
02/11/202213h05TipRanksNoble Financial Keeps Their Buy Rating on Axcella Health (AXLA)NASDAQ:AXLAAxcella Health Inc
02/11/202211h50TipRanksAnalysts Offer Insights on Healthcare Companies: Unity Biotechnology (UBX) and Axcella Health (AXLA)NASDAQ:AXLAAxcella Health Inc
18/10/202214h13TipRanksThis Insider Bought Axcella Health (NASDAQ:AXLA) Stock Worth $6MNASDAQ:AXLAAxcella Health Inc
17/10/202222h33Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AXLAAxcella Health Inc
17/10/202222h32Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:AXLAAxcella Health Inc
13/10/202213h56Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:AXLAAxcella Health Inc
 Showing the most relevant articles for your search:NASDAQ:AXLA